 WATERTOWN, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- Lyra Therapeutics, Inc. Nasdaq: LYRA, a clinical-stage therapeutics company leveraging its proprietary XTreoTM platform to enable precise, sustained, and local delivery of medications to the ear, nose and throat ENT passages and other diseased tissues, today announced that Maria Palasis, Ph.D., Lyras President and Chief Executive Officer, will present in a virtual format at the H.C. Wainwright 23rd Annual Global Investment Conference. The presentation will be made available for on-demand viewing on Monday, September 13, 2021 at 7:00 a.m. ET. 